2008/12/13 by Robin de Vries, Rogier Klok, Rogier M. Klok +3 · 1 citation
Medicine · #Biology #Cost effectiveness #Cost–benefit analysis #Environmental health #Eosinophilic Esophagitis #Gastroesophageal reflux and treatments #Helicobacter pylori #Helicobacter pylori-related gastroenterology studies #Immunology #Internal medicine #Medicine #Population #Risk analysis (engineering) #Vaccination
paper · pdf · doi:10.1016/j.vaccine.2008.11.081
openalex publication_date 2008/12/13 · crossref created 2008/12/13 · crossref issued 2009/02/01 · crossref published 2009/02/01 · crossref published-print 2009/02/01 · crossref deposited 2019/05/16 · openalex created_date 2025/10/10 · crossref indexed 2025/11/07 · openalex updated_date 2026/08/01